Mon.Nov 27, 2023

article thumbnail

Chest pain and new regional/reciprocal ECG changes compared to previous ECGs: code STEMI?

Dr. Smith's ECG Blog

Written by Jesse McLaren A 45 year old presented with two weeks of recurring non-exertional chest pain, now constant for an hour. Below is old and then new ECG (old on top; new below). What do you think? Both ECGs have normal sinus rhythm, normal conduction and normal voltages. There’s a change in axis that may interfere with direct lead-to-lead comparison, but there appear to be larger T waves in I/aVL and new TWI in III/aVF.

article thumbnail

Use of loop diuretics in patients with chronic heart failure: an observational overview

Open Heart

Introduction This study aimed to evaluate the use and dose of loop diuretics (LDs) across the entire ejection fraction (EF) spectrum in a large, ‘real-world’ cohort of chronic heart failure (HF) patients. Methods A total of 10 366 patients with chronic HF from 34 Dutch outpatient HF clinics were analysed regarding diuretic use and diuretic dose.

article thumbnail

5 Benefits of Switching to New Medical Image Sharing Software

NOVARAD

The medical industry has long been burdened by challenges associated with outdated and inefficient medical image sharing systems. These antiquated mechanisms hinder timely access to vital imagery, causing delays in diagnoses and treatment and ultimately compromising patient care.

article thumbnail

Superiority of left heart deformation in early anthracycline-related cardiac dysfunction detection

Open Heart

Objective This study aimed to assess the incidence of early cancer therapy-related cardiac dysfunction (CTRCD) and the characteristics of left and right heart deformations during anthracycline chemotherapy. Methods We prospectively enrolled a cohort of 351 chemotherapy-naïve women with breast cancer and cardiovascular risk factors who were scheduled to receive anthracycline.

Cancer 52
article thumbnail

Non-COVID-19 cardiovascular pathology from return-to-play screening in college athletes after COVID-19

Heart BMJ

Objective Concerns for cardiac involvement after SARS-CoV-2 infection led to widespread cardiac testing in athletes. We examined incidental non-COVID-19 cardiovascular pathology in college athletes undergoing postinfection return-to-play screening. Methods The Outcomes Registry for Cardiac Conditions in Athletes was a nationwide prospective multicentre observational cohort study that captured testing and outcomes data from 45 institutions (September 2020–June 2021).

article thumbnail

Primary versus iatrogenic (post-PCI) coronary microvascular dysfunction: a wire-based multimodal comparison

Open Heart

Background Although there are studies examining each one separately, there are no data in the literature comparing the magnitudes of the iatrogenic, percutaneous coronary intervention (PCI)-induced, microvascular dysfunction (Type-4 CMD) and coronary microvascular dysfunction (CMD) in the setting of ischaemia in non-obstructed coronary arteries (INOCA) (Type-1 CMD).

52
article thumbnail

Restoration of right ventricular function in the treatment of pulmonary arterial hypertension

Heart BMJ

Objective A 45% threshold of right ventricular ejection fraction (RVEF) is proposed clinically relevant in patients with pulmonary arterial hypertension (PAH). We aim to determine treatment response, long-term right ventricular (RV) functional stability and prognosis of patients with PAH reaching or maintaining the RVEF 45% threshold. Methods Incident, treatment-naive, adult PAH patients with cardiac magnetic resonance imaging at baseline and first follow-up were included (total N=127) and follo

More Trending

article thumbnail

Prediction of worsening heart failure in hypertrophic cardiomyopathy using plasma proteomics

Heart BMJ

Objective Heart failure (HF) is one of the most common and lifestyle-limiting complications of hypertrophic cardiomyopathy (HCM). Prediction of worsening HF using clinical measures alone remains limited. Moreover, the mechanisms by which patients with HCM develop worsening HF have not been elucidated. Therefore, the aim of this study was to develop a plasma proteomics-based model to predict worsening HF among patients with HCM and to identify signalling pathways that are differentially regulated

article thumbnail

Twelve-month follow-up effects of cognitive training after heart valve surgery on cognitive functions and health-related quality of life: a randomised clinical trial

Open Heart

Objectives Postoperative cognitive decline (POCD) or decreased health-related quality of life (HQL) have been reported after cardiac surgery. A previous investigation showed beneficial effects of postoperative cognitive training on POCD and HQL 3 months after heart surgery. Here, we present the 12-month follow-up results. Methods This bicentric, 1:1 randomised and treatment-as-usual controlled trial included elderly patients scheduled for elective heart valve surgery.

article thumbnail

Paired risk scores to predict ischaemic and bleeding risk twenty-eight days to one year after an acute coronary syndrome

Heart BMJ

Objective The recommended duration of dual anti-platelet therapy (DAPT) following acute coronary syndrome (ACS) varies from 1 month to 1 year depending on the balance of risks of ischaemia and major bleeding. We designed paired ischaemic and major bleeding risk scores to inform this decision. Methods New Zealand (NZ) patients with ACS investigated with coronary angiography are recorded in the All NZ ACS Quality Improvement registry and linked to national health datasets.

article thumbnail

Cardioneuroablation for reflex asystolic syncope – mid-term safety, efficacy and patient’s acceptance.

HeartRhythm

Cardioneuroablation (CNA) is a promising therapy for reflex asystolic syncope, however, convincing data on the mid-term safety and efficacy of this procedure are still lacking.

40
article thumbnail

Heartbeat: Proteomics for predicting risk and identifying mechanisms of disease progression

Heart BMJ

Proteomic profiling allows measurement of thousands of proteins simultaneously from blood or tissue samples in patients with cardiovascular disease which offers the promise of both improved risk prediction and identification of pathways instrumental in disease progression. In a multi-centre prospective cohort study of 389 patients with hypertrophic cardiomyopathy (HCM), Lumish and colleagues 1 derived and validated an 11-protein proteomics-based model to predict worsening heart failure (HF) over

article thumbnail

Endovascular Recanalization for Nonacute Carotid Artery Occlusion: A Nationwide Registry?Based Cohort Study

Stroke: Vascular and Interventional Neurology

Stroke: Vascular and Interventional Neurology, Ahead of Print. BACKGROUNDThe management of nonacute symptomatic internal carotid artery occlusion remains unsatisfactory. Endovascular recanalization has been reported to be feasible but associated with a noteworthy risk of postprocedural complications in patients with symptomatic internal carotid artery occlusion.

article thumbnail

Measuring long-term heart stress dynamics with smartwatch data

Science Daily - Heart Disease

Biomedical engineers have developed a method using data from wearable devices such as smartwatches to digitally mimic an entire week's worth of an individual's heartbeats. The new 'digital twins' computational framework captures personalized arterial forces over 700,000 heartbeats to better predict risks of heart disease and heart attack. The advance is an important step toward evaluating the risks of heart disease or heart attack over months to years.

article thumbnail

How Often Do Patients Need Retreatment After Surgery for Subdural Hematoma? A Nationwide Readmission Database Analysis

Stroke: Vascular and Interventional Neurology

Stroke: Vascular and Interventional Neurology, Ahead of Print. BACKGROUNDThe incidence of subdural hematoma is increasing as the average age in the United States rises, with reported high recurrence and reoperation rates. We therefore aimed to have a better understanding of retreatment following surgical evacuation of subdural hematoma in real‐world practice.METHODSData were extracted from the latest available Nationwide Readmissions Database (2016–2019).

Stroke 40
article thumbnail

Left atrial strain is a good predictor of atrio?ventricular synchrony in leadless pacemaker pacing

Journal of Cardiovascular Electrophysiology

Abstract Introduction The importance of atrio-ventricular synchrony pacing in sinus rhythm patients is known. To identify patients in whom leadless pacemakers are able to guarantee this atrio-ventricular synchrony, we explored correlations among echocardiographic measures of left atrial (LA) size and function (doppler parameter and strain) with A4 amplitude in patients implanted with new generation Micra-AV device.

article thumbnail

Difficult echocardiogram after pericardiocentesis

Heart BMJ

Clinical introduction A patient in their 70s, a heavy smoker with low body max index (17 kg/m 2 ) already known for previous relapses of pericarditis on echocardiographic follow-up, was admitted for worsening pericardial effusion ( figure 1A,B ; ). Given initial signs of cardiac tamponade, the patient underwent urgent pericardiocentesis (subxiphoid approach) with drainage of 1500 cc of pericardial fluid, without evident complications.

article thumbnail

Cardiac resynchronization using fusion pacing during exercise

Journal of Cardiovascular Electrophysiology

Abstract Introduction Fusion pacing requires correct timing of left ventricular pacing to right ventricular activation, although it is unclear whether this is maintained when atrioventricular (AV) conduction changes during exercise. We used cardiopulmonary exercise testing (CPET) to compare cardiac resynchronization therapy (CRT) using fusion pacing or fixed AV delays (AVD).

article thumbnail

Burden and prognostic impact of cardiovascular disease in patients with cancer

Heart BMJ

The number of patients at the intersection of cancer and cardiovascular disease (CVD) is increasing, reflecting ageing global populations, rising burden of shared cardiometabolic risk factors, and improved cancer survival. Many cancer treatments carry a risk of cardiotoxicity. Baseline cardiovascular risk assessment is recommended in all patients with cancer and requires consideration of individual patient risk and the cardiotoxicity profile of proposed anticancer therapies.

article thumbnail

Managing ventricular arrhythmias and implantable cardiac defibrillator shocks after left ventricular assist device implantation

Journal of Cardiovascular Electrophysiology

Abstract Continuous flow left ventricular assist devices (CF-LVADs) have been shown to reduce mortality and morbidity in patients with advanced heart failure with reduced ejection fraction. However, ventricular arrhythmias (VA) are common, are mostly secondary to underlying myocardial scar, and have a higher incidence in patients with pre-LVAD VA. Sustained VA is well tolerated in the LVAD patient but can result in implantable defibrillator (ICD) shocks, right ventricular failure, hospitalizatio

article thumbnail

Relationship between the aortic root and the atrioventricular conduction axis

Heart BMJ

Damage to the atrioventricular conduction axis continues to be a problem subsequent to transcatheter implantation of aortic valvar prostheses. Accurate knowledge of the precise relationships of the conduction axis relative to the aortic root could greatly reduce the risk of such problems. Current diagrams highlighting these relationships rightly focus on the membranous septum.

Aortic 40
article thumbnail

Repeat pulmonary vein isolation and anterior line ablation using a novel point-by-point pulsed field ablation system

HeartRhythm

Pulsed field ablation (PFA) is a nonthermal energy source for ablation of cardiac arrhythmias. This study investigated the prospective outcomes of a novel PFA generator in conjunction with a commercially available, contact force-sensing, focal ablation catheter.

article thumbnail

One step closer to the new frontiers of healthcare for cardiomyopathy patients

Heart BMJ

There were great advances in the treatment of heart failure (HF) over the past decades, characterised by the inclusion of ARNI and SGLT2 inhibitors in the latest guidelines. The use of cardiac myosin inhibitors specifically for patients with hypertrophic cardiomyopathy (HCM) is also making large steps forward, which reflects the next step towards more personalised treatment. 1 The increasing repertoire of treatments makes it even more important to select those patients who will benefit the most

article thumbnail

Pulsed field ablation of an atypical macro-reentrant tachycardia in the right atrium.

HeartRhythm

Pulse field ablation (PFA) using a pentaspline catheter is an effective and safe treatment method for pulmonary vein isolation (PVI) in patients with atrial fibrillation (AF).1,2 However, the efficacy and safety of PFA for non PV targets is largely unknown. We present a case of a macro-reentrant atrial tachycardia in the lateral right atrium (RA) treated by PFA using a pentaspline catheter.

article thumbnail

Novel risk score to predict ischaemic and bleeding risk after acute coronary syndrome: new tools for an upcoming new era?

Heart BMJ

It is not the strongest of the species that survives, nor the most intelligent that survives. It is the one that is the most adaptable to change. (Charles Darwin) Despite being proposed more than three decades ago, dual antiplatelet therapy has become a cornerstone of medical treatment for patients suffering from acute coronary syndrome after the introduction of bare metal stents to overcome the risk of restenosis and stent thrombosis associated with such devices.

article thumbnail

Oxidized high-density lipoprotein associates with atrial fibrillation

HeartRhythm

Atrial fibrillation (AF) is the most common heart arrhythmia and considered to be a progressive chronic disease associated with an increased morbidity and mortality. Recent data suggests a link between inflammation, oxidative stress and AF, although the underlying mechanisms are not fully understood. As oxidized lipoproteins cause structural damage and electrophysiologic changes in cardiomyocytes, it is feasible that the transformation of atheroprotective high-density lipoprotein (HDL) into dysf

article thumbnail

Asynchronous communication for medical journal editorial teams in a diverse global research community

Heart BMJ

Medical journal editors face many challenges in the ongoing transformation of scientific publishing including the replacement of print by digital publication, the proliferation of journals, increasing emphasis on open access and the introduction of preprint websites. Historically, the evolution of journal editorship reflects the changing environment and standards for scientific publishing. 1 Over the past 50 years, it has become established that an essential function of a medical journal is to p

article thumbnail

ATRIAL TACHYARRHYTHMIAS IN ARRHYTHMOGENIC CARDIOMYOPATHY

HeartRhythm

Arrhythmogenic cardiomyopathy (ACM) is a heart muscle disease characterized by replacement of ventricular myocardial by fibrofatty scar tissue which underlies morpho-functional ventricular abnormalities and life-threatening ventricular arrhythmias potentially responsible of sudden cardiac death (SCD), mostly in young people and athletes 1,2. Although the original disease phenotype was characterized by a predominant right ventricular (RV) involvement (arrhythmogenic right ventricular cardiomyopat

article thumbnail

New study emphasizes the importance of cardiovascular health in postpartum care

Becker's Hospital Review - Cardiology

Continuing regular check-ups for some mothers into the "fourth-trimester" — the three month after giving birth —may help reduce cardiovascular-related deaths, a top indirect cause of maternal deaths, according to the American Heart Association.

40
article thumbnail

Fourth Trimester: Assessing Women’s Health Equity and Long-Term Cardiovascular Outcomes in a Large Midwestern Health System in 2021

Circulation: Cardiovascular Quality & Outcomes

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print.

article thumbnail

What is wrong with the NHS? – Part 3

Dr. Malcolm Kendrick

27th November 2023 Relentlessly falling productivity (Part a). Regulatory constraints. I was in the midst of writing another blog on what is wrong with the NHS, happily highlighting a few of the many pointless tasks that get in the way of clinical work. But my attention kept being drawn to the more general issue of the widespread fall in productivity.

article thumbnail

Differences in risk and costs between prehospital identified low-risk men and women with chest pain

Open Heart

Objective Prehospital rule-out of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) in low-risk patient with a point-of-care troponin measurement reduces healthcare costs with similar safety to standard transfer to the hospital. Risk stratification is performed identical for men and women, despite important differences in clinical presentation, risk factors and age between men and women with NSTE-ACS.

article thumbnail

Exploring the mechanisms responsible for reduced systolic function in high-gradient aortic stenosis

Heart BMJ

Objective To characterise the mechanics responsible for the reduced ejection fraction (rEF) in high-gradient severe aortic stenosis (AS). Methods 21 patients with high-gradient severe AS (aortic valve area (AVA) <1.0 cm 2 and mean gradient (MG) >40 mm Hg) were included. They included 9 patients with rEF (EF <50%) and 12 with preserved ejection fraction (pEF) (EF >50%).

article thumbnail

Pulsed?field versus cryoballoon ablation for atrial fibrillation—Impact of energy source on sedation and analgesia requirement

Journal of Cardiovascular Electrophysiology

Abstract Introduction Pulsed field ablation (PFA) represents a novel, nonthermal energy modality that can be applied for single-shot pulmonary vein isolation (PVI) in atrial fibrillation (AF). Comparative data with regard to deep sedation to established single-shot modalities such as cryoballoon (CB) ablation are scarce. The aim of this study was to compare a deep sedation protocol in patients receiving PVI with either PFA or CB.

article thumbnail

Sleep-disordered breathing and cardiovascular disease: who and why to test and how to intervene?

Heart BMJ

Sleep-disordered breathing (SDB) is common in individuals with established cardiovascular disease (CVD), particularly those with heart failure (HF). There are two main types of SDB, central sleep apnoea (CSA) and obstructive sleep apnoea (OSA) which frequently overlap as mixed SDB. Investigating for SDB could be considered in patients with excessive daytime sleepiness, male sex, high body mass index, low ejection fraction, atrial fibrillation (AF), in patients with no dipping blood pressure patt